Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tara Sotsky Kent, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Tara Kent and Mark Callery.
Tara Kent
Connection Strength
4.196
Mark Callery
  1. Conditional survival in pancreatic cancer: better than expected. HPB (Oxford). 2011 Dec; 13(12):876-80.
    View in: PubMed
    Score: 0.498
  2. Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma. World J Gastrointest Surg. 2010 10 27; 2(10):319-23.
    View in: PubMed
    Score: 0.468
  3. Language Proficiency and Survival in Pancreatic Cancer: a Propensity Score-Matched Analysis. J Gastrointest Surg. 2021 Jul 13.
    View in: PubMed
    Score: 0.246
  4. Braden scale for pressure ulcer risk predicts rehabilitation placement after pancreatic resection. HPB (Oxford). 2019 07; 21(7):923-927.
    View in: PubMed
    Score: 0.206
  5. Readmission following pancreatectomy: what can be improved? HPB (Oxford). 2013 Sep; 15(9):703-8.
    View in: PubMed
    Score: 0.138
  6. Quality assessment in pancreatic surgery: what might tomorrow require? J Gastrointest Surg. 2013 Jan; 17(1):86-93; discussion p.93.
    View in: PubMed
    Score: 0.135
  7. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013 Jan; 216(1):1-14.
    View in: PubMed
    Score: 0.135
  8. The burden of infection for elective pancreatic resections. Surgery. 2013 Jan; 153(1):86-94.
    View in: PubMed
    Score: 0.131
  9. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011 Oct; 213(4):515-23.
    View in: PubMed
    Score: 0.124
  10. Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e615-22.
    View in: PubMed
    Score: 0.122
  11. The bridge stent technique for salvage of pancreaticojejunal anastomotic dehiscence. HPB (Oxford). 2010 Oct; 12(8):577-82.
    View in: PubMed
    Score: 0.116
  12. Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms. HPB (Oxford). 2010 Mar; 12(2):115-22.
    View in: PubMed
    Score: 0.112
  13. A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better. Surgery. 2021 Aug 22.
    View in: PubMed
    Score: 0.062
  14. Procedure-specific Training for Robot-assisted Distal Pancreatectomy. Ann Surg. 2021 07 01; 274(1):e18-e27.
    View in: PubMed
    Score: 0.061
  15. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. Surgery. 2021 Oct; 170(4):1195-1204.
    View in: PubMed
    Score: 0.061
  16. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development. Surgery. 2021 04; 169(4):708-720.
    View in: PubMed
    Score: 0.059
  17. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy. Ann Surg. 2020 Nov 12.
    View in: PubMed
    Score: 0.059
  18. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy. Ann Surg. 2020 Jun 11.
    View in: PubMed
    Score: 0.057
  19. Biliary palliation for unresectable pancreatic adenocarcinoma: surgical bypass or self-expanding metal stent? HPB (Oxford). 2020 04; 22(4):563-569.
    View in: PubMed
    Score: 0.054
  20. Does surgical approach affect outcomes of enucleation for benign and low-grade pancreatic tumors? An ACS-NSQIP evaluation. HPB (Oxford). 2019 11; 21(11):1585-1591.
    View in: PubMed
    Score: 0.053
  21. Transversus abdominis plane block reduces pain and narcotic consumption after robot-assisted distal pancreatectomy. HPB (Oxford). 2019 08; 21(8):1039-1045.
    View in: PubMed
    Score: 0.052
  22. Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group. Ann Surg. 2019 01; 269(1):143-149.
    View in: PubMed
    Score: 0.052
  23. Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy. Ann Surg. 2018 04; 267(4):608-616.
    View in: PubMed
    Score: 0.049
  24. Unique predictors and economic burden of superficial and deep/organ space surgical site infections following pancreatectomy. HPB (Oxford). 2018 07; 20(7):658-668.
    View in: PubMed
    Score: 0.049
  25. Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma. HPB (Oxford). 2018 06; 20(6):573-581.
    View in: PubMed
    Score: 0.048
  26. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study. J Gastrointest Surg. 2018 02; 22(2):214-225.
    View in: PubMed
    Score: 0.047
  27. Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? J Gastrointest Surg. 2018 01; 22(1):88-97.
    View in: PubMed
    Score: 0.047
  28. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies. J Gastrointest Surg. 2018 01; 22(1):68-76.
    View in: PubMed
    Score: 0.047
  29. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Cancer. 2017 Nov 01; 123(21):4158-4167.
    View in: PubMed
    Score: 0.047
  30. Incorporation of Procedure-specific Risk Into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality After Pancreatoduodenectomy. Ann Surg. 2017 05; 265(5):978-986.
    View in: PubMed
    Score: 0.046
  31. Pancreas fistula risk prediction: implications for hospital costs and payments. HPB (Oxford). 2017 02; 19(2):140-146.
    View in: PubMed
    Score: 0.045
  32. Externalized Stents for Pancreatoduodenectomy Provide Value Only in High-Risk Scenarios. J Gastrointest Surg. 2016 12; 20(12):2052-2062.
    View in: PubMed
    Score: 0.044
  33. Hemorrhage after pancreaticoduodenectomy: does timing matter? HPB (Oxford). 2016 10; 18(10):861-869.
    View in: PubMed
    Score: 0.044
  34. Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation. Ann Surg. 2016 Aug; 264(2):344-52.
    View in: PubMed
    Score: 0.044
  35. Early surgical bypass versus endoscopic stent placement in pancreatic cancer. HPB (Oxford). 2016 08; 18(8):671-7.
    View in: PubMed
    Score: 0.043
  36. Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer. J Cancer. 2016; 7(3):283-8.
    View in: PubMed
    Score: 0.042
  37. Comparing the burden of pancreatic fistulas after pancreatoduodenectomy and distal pancreatectomy. Surgery. 2016 Apr; 159(4):1013-22.
    View in: PubMed
    Score: 0.042
  38. A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. J Gastrointest Surg. 2016 Jan; 20(1):85-92; discussion 92.
    View in: PubMed
    Score: 0.041
  39. Surgical management of chronic pancreatitis: current utilization in the United States. HPB (Oxford). 2015 Sep; 17(9):804-10.
    View in: PubMed
    Score: 0.041
  40. The Characterization and Prediction of ISGPF Grade C Fistulas Following Pancreatoduodenectomy. J Gastrointest Surg. 2016 Feb; 20(2):262-76.
    View in: PubMed
    Score: 0.041
  41. A nationwide assessment of outcomes after bile duct reconstruction. HPB (Oxford). 2015 Sep; 17(9):753-62.
    View in: PubMed
    Score: 0.040
  42. Technique and outcomes of robot-assisted median arcuate ligament release for celiac artery compression syndrome. J Vasc Surg. 2015 May; 61(5):1278-84.
    View in: PubMed
    Score: 0.039
  43. Robotic surgery for benign duodenal tumors. J Gastrointest Surg. 2015 Feb; 19(2):306-12.
    View in: PubMed
    Score: 0.039
  44. Prophylactic octreotide for pancreatoduodenectomy: more harm than good? HPB (Oxford). 2014 Oct; 16(10):954-62.
    View in: PubMed
    Score: 0.038
  45. Patient selection and the volume effect in pancreatic surgery: unequal benefits? HPB (Oxford). 2014 Oct; 16(10):899-906.
    View in: PubMed
    Score: 0.038
  46. Rankings versus reality in pancreatic cancer surgery: a real-world comparison. HPB (Oxford). 2014 Jun; 16(6):528-33.
    View in: PubMed
    Score: 0.036
  47. Assessing the impact of a fistula after a pancreaticoduodenectomy using the Post-operative Morbidity Index. HPB (Oxford). 2013 Oct; 15(10):781-8.
    View in: PubMed
    Score: 0.035
  48. The pancreaticojejunal anastomotic stent: friend or foe? Surgery. 2013 May; 153(5):651-62.
    View in: PubMed
    Score: 0.034
  49. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma. HPB (Oxford). 2013 Jan; 15(1):49-60.
    View in: PubMed
    Score: 0.033
  50. A root-cause analysis of mortality following major pancreatectomy. J Gastrointest Surg. 2012 Jan; 16(1):89-102; discussion 102-3.
    View in: PubMed
    Score: 0.031
  51. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures. HPB (Oxford). 2010 Sep; 12(7):482-7.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.